Wayfinding Financial, LLC Pfizer Inc Transaction History

Wayfinding Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $49,939 - $58,519	-1,977 Reduced 19.85%	7,982 $223,000
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $24,854 - $28,540	960 Added 10.67%	9,959 $276,000
Q4 2023 Jan 09, 2024	SELL	$26.13 - $33.94 $11,235 - $14,594	-430 Reduced 4.56%	8,999 $259,000
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $15,050 - $17,592	469 Added 5.23%	9,429 $312,000
Q2 2023 Jul 31, 2023	BUY	$36.12 - $41.79 $25,934 - $30,005	718 Added 8.71%	8,960 $328,000
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $28,912 - $37,639	734 Added 9.78%	8,242 $336,000
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $36,322 - $47,415	-870 Reduced 10.38%	7,508 $400,000
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $25,555 - $31,197	584 Added 7.49%	8,378 $366,000
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $12,981 - $15,392	279 Added 3.71%	7,794 $408,000
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $320 - $396	7 Added 0.09%	7,515 $368,000
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $310,230 - $459,865	7,508 New	7,508 $400,000

3,271

3.63B

74.3M

107M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $146B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Wayfinding Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Wayfinding Financial, LLC with notifications on news.